Literature DB >> 1811769

Delirium: phenomenologic and etiologic subtypes.

C A Ross1, C E Peyser, I Shapiro, M F Folstein.   

Abstract

While all delirious patients have clouding of consciousness (alteration of attention) and cognitive dysfunction, the level of alertness of different patients may range from stuporous to hyperalert. We, therefore, developed an analog scale to rate the alertness of delirious patients, and a separate scale to rate the severity of their clouding of consciousness. Based on these scales, patients were categorized overall as relatively "activated" (relatively alert despite clouding of consciousness), or "somnolent" (relatively stuporous along with clouding of consciousness). Cognitive function was estimated using the Mini-Mental Status Exam. Separate ratings were made of hallucinations, delusions, illusions, and agitated behavior. Activated and somnolent patients had similar ages, overall severity of delirium, and Mini-Mental Status Exam scores. Activated patients, however, were more likely to have hallucinations, delusions, and illusions than somnolent patients, and were more likely to have agitated behavior. Patients with hepatic encephalopathy were more likely to have somnolent delirium, while patients with alcohol withdrawal appeared more likely to have activated delirium. These data indicate that phenomenologic subtypes of delirium can be defined on the basis of level of alertness. These subtypes are validated in part by their differing associations with symptoms unrelated to alertness. These subtypes may have different pathophysiology, and thus, potentially different treatments.

Entities:  

Mesh:

Year:  1991        PMID: 1811769     DOI: 10.1017/s1041610291000613

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  16 in total

Review 1.  Drug-induced delirium. Incidence, management and prevention.

Authors:  G L Carter; A H Dawson; R Lopert
Journal:  Drug Saf       Date:  1996-10       Impact factor: 5.606

2.  Stability of postoperative delirium psychomotor subtypes in individuals with hip fracture.

Authors:  Jennifer S Albrecht; Edward R Marcantonio; Darren M Roffey; Denise Orwig; Jay Magaziner; Michael Terrin; Jeffrey L Carson; Erik Barr; Jessica P Brown; Emma G Gentry; Ann L Gruber-Baldini
Journal:  J Am Geriatr Soc       Date:  2015-05-04       Impact factor: 5.562

Review 3.  Benzodiazepines for agitation in patients with delirium: selecting the right patient, right time, and right indication.

Authors:  David Hui
Journal:  Curr Opin Support Palliat Care       Date:  2018-12       Impact factor: 2.302

4.  Delirium episodes during the course of clinically diagnosed Alzheimer's disease.

Authors:  F M Baker; C Wiley; E Kokmen; V Chandra; B S Schoenberg
Journal:  J Natl Med Assoc       Date:  1999-11       Impact factor: 1.798

Review 5.  Psychotic manifestations of alcoholism.

Authors:  D M Greenberg; J W Lee
Journal:  Curr Psychiatry Rep       Date:  2001-08       Impact factor: 5.285

Review 6.  Delirium in the older emergency department patient: a quiet epidemic.

Authors:  Jin H Han; Amanda Wilson; E Wesley Ely
Journal:  Emerg Med Clin North Am       Date:  2010-08       Impact factor: 2.264

Review 7.  Neuroleptics in the management of delirium in patients with advanced cancer.

Authors:  David Hui; Rony Dev; Eduardo Bruera
Journal:  Curr Opin Support Palliat Care       Date:  2016-12       Impact factor: 2.302

8.  Olanzapine vs haloperidol: treating delirium in a critical care setting.

Authors:  Yoanna K Skrobik; Nicolas Bergeron; Marc Dumont; Stewart B Gottfried
Journal:  Intensive Care Med       Date:  2003-12-19       Impact factor: 17.440

Review 9.  Clarifying delirium management: practical, evidenced-based, expert recommendations for clinical practice.

Authors:  Scott A Irwin; Rosene D Pirrello; Jeremy M Hirst; Gary T Buckholz; Frank D Ferris
Journal:  J Palliat Med       Date:  2013-03-12       Impact factor: 2.947

Review 10.  Altered mental status in older patients in the emergency department.

Authors:  Jin H Han; Scott T Wilber
Journal:  Clin Geriatr Med       Date:  2013-02       Impact factor: 3.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.